Hill-Rom Holdings Inc (HRC) 50.27 $HRC United States

New Post Public Reply Private Reply Replies (0) Message Board

Jun 24, 2016 at 8:17 PM

Hill-Rom Holdings Inc (HRC) 50.27 $HRC

United States Mobility Aids and Transportation Equipment Market Outlook to 2021 - Key Players are Stryker, Invacare & Hill-Rom Holdings - Research and Markets
BusinessWire - Tue Jun 21, 12:13PM CDT
Research and Markets has announced the addition of the "United States Mobility Aids and Transportation Equipment Market Outlook to 2021" report to their offering.
IVC: 11.53 (-0.63), HRC: 50.27 (-1.79)

Hill-Rom Introduces VisiVest, First Connected Airways System
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:19AM CDT
Hill-Rom Holdings, Inc. (HRC) recently launched VisiVest System, the world's first wirelessly connected airway clearance system.
ICUI: 106.49 (-1.64), LMAT: 14.42 (-0.40), NUVA: 57.93 (-0.93), HRC: 50.27 (-1.79)

Hill-Rom Holdings (HRC) Looks Good: Stock Adds 5.4% in Session
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:40AM CDT
Hill-Rom Holdings, Inc. (HRC) saw its shares rise almost 7% in the last trading session.
BAX: 43.85 (-2.11), HRC: 50.27 (-1.79)

Upgrade Alert for Hill-Rom Holdings (HRC)
Comtex SmarTrend(R) - Fri Jun 17, 3:05AM CDT
Hill-Rom Holdings (NYSE:HRC) was upgraded from Equal Weight to Overweight at Morgan Stanley today. The stock closed yesterday at $51.56 on volume of 1.3 million shares, above average daily volume of 540,000. Over the past year, Hill-Rom Holdings has traded in a range of $42.99 to $58.73 and closed yesterday at $51.55, 20% above that low. The 200-day and 50-day moving averages have moved 0.31% lower and 0.32% higher over the past week, respectively.
HRC: 50.27 (-1.79)

Hill-Rom: Welch-Allyn Buyout Drives Q2, Forex Woes Stay
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:20AM CDT
Hill-Rom (HRC) posted a mixed second quarter of fiscal 2016 with the bottom line surpassing the Zacks Consensus Estimate and the top line missing the same.
BSX: 22.37 (-0.60), BAX: 43.85 (-2.11), LMAT: 14.42 (-0.40), HRC: 50.27 (-1.79)

Hill-Rom to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference
PR Newswire - Tue May 24, 9:00AM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs 37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, at 11:00 a.m. EDT.
HRC: 50.27 (-1.79)

Hill-Rom to Participate in the Goldman Sachs First Annual Leveraged Finance Conference
PR Newswire - Fri May 06, 1:30PM CDT
Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a management presentation at the Goldman Sachs First Annual Leveraged Finance Conference on Tuesday, May 17, 2016, at 8:10 p.m. EDT.
HRC: 50.27 (-1.79)

Hill-Rom Declares Third Quarter 2016 Dividend
PR Newswire - Fri May 06, 8:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that its Board of Directors declared a fiscal year 2016 third quarter dividend of $0.17 per share. This quarterly dividend represents a 6 percent increase over the amount paid a year ago. The dividend is payable on June 24, 2016, to shareholders of record as of the close of business on June 10, 2016.
HRC: 50.27 (-1.79)

Hill-Rom (HRC) Q2 Earnings Beat, Revenue Lag Estimates
Zacks Equity Research - Zacks Investment Research - Wed May 04, 8:05AM CDT
Hill-Rom (HRC) ended second-quarter fiscal 2016 on a mixed note with the bottom line surpassing the Zacks Consensus Estimate and top line missing the mark.
BSX: 22.37 (-0.60), SRDX: 23.32 (-0.74), BAX: 43.85 (-2.11), HRC: 50.27 (-1.79)

Hill-Rom to Participate in the Bank of America Merrill Lynch 2016 Health Care Conference
PR Newswire - Tue May 03, 12:00PM CDT
Hill-Rom Holdings, Inc. (NYSE:HRC) invites you to listen to a management presentation at the Bank of America Merrill Lynch 2016 Health Care Conference on Tuesday, May 10, 2016, at 5:20 p.m. EDT.
HRC: 50.27 (-1.79)

Hill-Rom tops 2Q profit forecasts
Automated Insights - Fri Apr 29, 5:37AM CDT
CHICAGO (AP) _ Hill-Rom Holdings Inc. (HRC) on Friday reported fiscal second-quarter earnings of $22.3 million.
HRC: 50.27 (-1.79)

Hill-Rom Reports Higher Year-Over-Year Revenue And Adjusted Earnings And Updates Full Year Outlook
PR Newswire - Fri Apr 29, 5:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced financial results for its second quarter ended March 31, 2016, and updated its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.71 represent an increase of 11 percent from $0.64 in the prior year, while reported earnings per diluted share decreased 27 percent from $0.45 to $0.33. Adjustments to reported earnings are detailed in the reconciliation schedules provided.
HRC: 50.27 (-1.79)

Hill-Rom to Participate in the Deutsche Bank 41st Annual Health Care Conference
PR Newswire - Tue Apr 26, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) invites you to listen to a management presentation at the Deutsche Bank 41st Annual Health Care Conference on Wednesday, May 4, 2016, at 2:50 p.m. EDT.
DB: 14.72 (-3.12), HRC: 50.27 (-1.79)

Hill-Rom Holdings, Inc. Hosts Fiscal 2016 Second Quarter Earnings Conference Call and Webcast
PR Newswire - Fri Apr 01, 10:30AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) will hold its fiscal 2016 second quarter earnings conference call and webcast on Friday, April 29, 2016, from 8:00 a.m. - 9:00 a.m. EDT.
HRC: 50.27 (-1.79)

Medtronic Unveils NURO System in US for Overactive Bladder
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:30PM CDT
We believe this product launch will allow Medtronic (MDT) to overcome the issues it has been facing in its Neuromodulation business division over the past couple of quarters
MDT: 83.26 (-2.51), OFIX: 42.75 (-1.47), HRC: 50.27 (-1.79), OSUR: 6.61 (-0.20)

Mead Johnson Launches Enfinitas Product Line in China
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:25PM CDT
Mead Johnson Nutrition Company (MJN) recently launched its Enfinitas premium-priced product line in China.
MJN: 87.55 (-1.06), BAX: 43.85 (-2.11), HRC: 50.27 (-1.79), OSUR: 6.61 (-0.20)

Quest Diagnostics Grows Through Organic, Inorganic Means
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:05PM CDT
On Mar 30, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
BAX: 43.85 (-2.11), DGX: 78.90 (-1.63), HRC: 50.27 (-1.79), OSUR: 6.61 (-0.20)

Cepheid Up on International Launch of Next-Gen MRSA Test
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 2:50PM CDT
Cepheid's (CPHD) Xpert MRSA NxG assay is a next-generation version of the market-leading molecular diagnostic test for Methicillin-Resistant Staphyloccus aureus (MRSA).
CPHD: 29.07 (-1.89), OFIX: 42.75 (-1.47), HRC: 50.27 (-1.79), OSUR: 6.61 (-0.20)

Stryker (SYK) Scales a 52-Week High: Right Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 11:40AM CDT
Shares of Stryker Corp (SYK) rallied to a new 52-week high of $106.92 on Mar 29, eventually closing a tad bit lower at $106.87.
BAX: 43.85 (-2.11), HRC: 50.27 (-1.79), OSUR: 6.61 (-0.20), SYK: 116.59 (-1.79)

Akers' Loss Widens in 2015, Revenues Deteriorate Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 9:46AM CDT
Akers Biosciences Inc. (AKER) reported loss of $1.81 per share in full-year 2015, much wider than 66 cents recorded in 2014.
AMZN: 698.96 (-23.12), BAX: 43.85 (-2.11), AKER: 1.92 (-0.08), HRC: 50.27 (-1.79)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sandvik's Q3 2026: Robust Growth Amid Market Shifts

Riding the Uptrend: Sandvik's Stirring Q3 Performance Let's break out the potato chips and dig into Sandvik's third-quarter numbers for 2026. This Stockholm machinery giant isn't just moving metal; it's moving the market needle in ways only a few can manage. You see, Sandvik pulled in an order intake of SEK 36,948 million, which ain't shabby when compared to last year's...

Sunlife Partners With Rippling to Streamline Benefits

Sunlife Enters the Tech Game It ain't your granddaddy's insurance world no more. Sunlife U.S. is hopping on the tech bandwagon, joining Rippling's Preferred Carrier Program to make employee benefits slicker and faster. This isn't just about insurance paperwork; it's about reshaping how businesses handle their payroll, IT, and HR under one digital roof. Why it Matters for...

Parents Miss Key Steps to Combat Childhood Myopia

A Growing Concern in Children's Vision Let’s face it, parents are grappling with a lot these days, and one area where they're playing catch up is in understanding childhood myopia. A recent AAV survey sheds some light on this and reveals that while parents may grasp the future risks of nearsightedness, they're stumbling over what simple steps today could stave off...

Flood Insurance: Crucial for Silver Spring Owners?

Flood Risk: A Reality Check for Homeowners Alright folks, let's dive into a topic that's been soaking up attention lately—flood insurance in Silver Spring, Maryland. Seems like everyone assumes they're safe from watery doom if they're standing outside those high-risk FEMA flood zones. But here's the kicker: Glenda Martinez, the big cheese at Xcella Insurance Group,...

Local Visibility Crisis Looms for Small Businesses

Scrolling through these fresh stats from BrightLocal's recent report, you can almost hear the alarm bells echoing across small towns and city squares. The data paints a surprisingly sobering picture: despite the fact that 71% of folks are heading straight to Google to find local businesses, only a mere 22% of small business owners are tagging it as one of their top tools...

Dr. Anke Otto-Wolf's BEFORE Framework Revolutionizes SEL

Teaching Kids to Catch Themselves: Introducing BEFORE Calling October Bullying Prevention Month seems quaint when you consider how often kids get shoved around, physically or emotionally. What’s surprising is how one simple word, ‘BEFORE,’ might just be the game-changer. Dr. Anke Otto-Wolf is betting big on it by unveiling the BEFORE Framework™. Imagine kids...

Indegene Gains Accolades for AI-Driven Pharma Success

Indegene's AI Revolution in Pharma There's a new player making noise on the pharma playground, and it's called Indegene. This company just snagged the 2026 Global Enabling Technology Leadership Recognition from Frost & Sullivan for shaking up pharmaceutical commercialization with its cutting-edge AI arsenal. No fluff here—just a straight dive into how they're turning...

Frost & Sullivan Boosts China Insight with LeadLeo

Navigating China's Complex Market Landscape You've got to understand, the stakes in China are like a high-wire act—mystifying and risky, yet bountiful if you play your cards right. Frost & Sullivan's latest maneuver into China's business intel scene is basically the lifeline for navigating this increasingly convoluted market. With China surging ahead in AI, biotech, and...

Littleton U-Pull-It Kicks off New Era with a Bang

A Fresh Chapter for Littleton U-Pull-It There's nothing quite like the thrill of a new beginning, especially when it promises to shake up the local business scene. Littleton U-Pull-It, under new ownership, seems to be gearing up for exactly that. They're setting the stage with a grand opening event on October 24. When old hands in the business world like me see moves like...

Millrose Faces Class Action: Blame Game in Motion

Millrose Properties: A Realty Ruckus Unfolding Sometimes, in the world of stocks, it feels like you're two steps ahead of the scam or already knee-deep in trouble. Millrose Properties, Inc. struck a rather sour chord recently with an 8.53% stock drop, leaving investors feeling the burn. Here's the juice: a securities fraud class action is in motion, and if you're holding...